概要

Teva Pharmaceuticals has been developing and producing medicines to help improve people’s lives for more than a century. We are committed to being a global leader in generic and specialty medicines with a portfolio of 3,500 products in nearly every therapeutic area. Around 200 million people around the world take a Teva medicine every day. They are served by one of the largest and most complex supply chains in the pharmaceutical industry. Along with our established presence in generics, we have significant innovative research and operations supporting our growing portfolio of specialty and biopharmaceutical products. Learn more at www.tevapharm.com. Please note that adverse effects for any of our products should be reported to: [email protected] Product-specific questions should be directed to Teva or Teva Group subsidiaries in your country. Contact details and Teva's Pharmacovigilance Privacy Policy may be found here: http://www.tevapharm.com/contact_us/

ウェブサイト
http://www.tevapharm.com
業種
医薬品製造業
会社規模
社員 10,001名以上
本社
Tel-Aviv
種類
上場企業
専門分野
generic medicines、specialty medicines、CNS、active pharmaceutical ingredients、respiratory、biosimilars、biologics、pain care、migraine、oncology

場所

Teva Pharmaceuticalsの社員

アップデート

系列企業ページ

類似するページ

資金調達

Teva Pharmaceuticals 合計3ラウンド

最終ラウンド

ポストIPO株式

$100,000,000.00

投資家およびグループ

Royalty Pharma
Crunchbaseで詳しい情報を表示